Tool
Supplement comparison tool
Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.
Add to comparison (2/4)
| Category | Choroby i zaburzenia | Choroby i zaburzenia |
| Evidence strength | Moderate evidence | Strong evidence |
| Evidence Score | 3/5 | 4/5 |
| User rating | 4.5 (38) | 4.7 (68) |
| Typical dose | — | — |
| Form | — | — |
| Average price | — | — |
| Monthly cost | — | — |
| Time to effects | A response to antihistamines and mast cell stabilizers, when MCAS is the actual cause of symptoms, is often noticeable within days to a few weeks of starting treatment — a complete lack of response to such therapy is itself one of the signals to revisit the diagnosis. | Densitometry measurements rarely show significant changes before several months — the network meta-analysis indicates that interventions lasting 52 weeks or longer produce more consistent, lasting effects than shorter programs. |
| Who it's for | People with recurring, episodic symptoms affecting several systems at once (skin, digestive tract, circulation, airways) | Perimenopausal and postmenopausal women |